Instructions

ZOOM IN by clicking on the page. A slider will appear, allowing you to adjust your zoom level. Return to the original size by clicking on the page again.

MOVE the page around when zoomed in by dragging it.

ADJUST the zoom using the slider on the top right.

ZOOM OUT by clicking on the zoomed-in page.

SEARCH by entering text in the search field and click on "In This Issue" or "All Issues" to search the current issue or the archive of back issues
respectively.
.

PRINT by clicking on thumbnails to select pages, and then press the
print button.

SHARE this publication and page.

ROTATE PAGE allows you to turn pages 90 degrees clockwise or counterclockwise.Click on the page to return to the original orientation. To zoom in on a rotated page, return the page to its original orientation, zoom in, and
then rotate it again.

CONTENTS displays a table of sections with thumbnails and descriptions.

ALL PAGES displays thumbnails of every page in the issue. Click on
a page to jump.

tues.12.feb.2013 Sponsored by
Advertising
partners
Supercomputer enlisted against cancer
WASHINGTON: IBM is putting its Watson supercomputer
to work fighting cancer, in what is described as the first
commercial program of its kind to use “big data” to help
patients with the disease.
The US computing giant last week unveiled its initiative
with health insurer WellPoint and Memorial Sloan-Kettering
Cancer Centre in New York.
The supercomputer, which gained fame by defeating two
human champions in the Jeopardy! quiz show, has been
sifting through some 600,000 pieces of medical evidence, two
million pages of text from 42 medical journals and clinical
trials in oncology research.
This can speed up the way data is analysed to make the
best diagnosis and find the optimal treatment, says Craig
Thompson, Sloan-Kettering’s president.
“It can take years for the latest developments in oncology to
reach all practice settings,” Thompson said.
“The combination of transformational technologies found
in Watson with our cancer analytics and decision-making
process has the potential to revolutionise the accessibility
of information for the treatment of cancer in communities
across the country and around the world.”
IBM first announced plans to work with WellPoint in 2011,
and last year began receiving data from the New York
research hospital which specialises in cancer.
The first application will work with 1500 lung cancer cases,
where clinicians and analysts are training Watson to extract
and interpret physician notes, lab
results and clinical research.
The Maine Centre... READ MORE
NEW YORK: Apple is testing a watch-like device that could
perform some smartphone functions, US media reports say.
The New York Times reported that the maker of iPhones and
iPads is experimenting with a curved-glass device, which
could incorporate a bendable display glass developed by US
manufacturer Corning.
The Times, which quoted sources who spoke on condition
of anonymity, said the device would likely use Apple’s iOS
platform, which is incorporated on the iPhone and iPad.
Although details were not clear, the report said the watch
could be used for mobile payments using Apple’s Passbook
software.
The Wall Street Journal said, meanwhile... READ MORE
Apple testing ‘smart watch’: reports
WATCH
VIDEO
CANBERRA: More than 750,000 pensioners will benefit
from a drop in deeming rates, the federal government says.
Pension deeming rates will be reduced from March 20.
The decision will provide part-rate pensioners with an
average pension increase of $6.80 per fortnight, Families
Minister Jenny Macklin said in a statement today.
Deeming rates reflect the standard rates of return that
pensioners can earn from their financial assets.
They are used to determine how much pensioners receive
under means-testing rules.
The lower deeming rate will decrease from three per cent
to 2.5 per cent for financial investments up to $45,400 for
single pensioners or $75,600 for a couple.
The upper deeming rate will decrease from 4.5 per cent to 4
per cent for balances over these amounts. READ MORE
Govt drops pension deeming rates
DAMASCUS: President Bashar al-Assad has vowed not to
bow to mounting pressure and “plots”, almost two years
into a deadly revolt in Syria, as at least 13 people were
killed when a car exploded just inside the Turkish border.
On the war front, rebels seized control of Syria’s largest
dam, a monitoring group said.
“Syria will remain the beating heart of the Arab world
and will not give up its principles despite the intensifying
pressure and diversifying plots not only targeting Syria,
but all Arabs,” Assad said, quoted by state news agency
SANA. READ MORE
Assad vows to resist as
blast hits border
IBM sells the benefits
of its Watson
supercomputer
The remains of cars after a blast at the Cilvegozu border crossing between
Turkey and Syria which killed at least 13 people. AFP photo
home
news/views
nation /world
business
sport
ispy
property
food&wine